Skip to main content

Advertisement

Log in

Pravastatin improves postprandial endothelial dysfunction and hemorheological deterioration in patients with effort angina pectoris

  • Original Article
  • Published:
Heart and Vessels Aims and scope Submit manuscript

Abstract

Postprandial hypertriglyceridemia and hyperglycemia may promote endothelial and hemorheological dysfunction. The present study investigated the effects of pravastatin on endothelial function and hemorheology in patients with stable angina pectoris (AP) before and after eating a test meal. We recruited 26 patients with stable AP who had impaired glucose tolerance and mild dyslipidemia and six healthy men as controls to assess endothelial function and hemorheological behavior. In each group, we measured forearm blood flow (FBF) during post-ischemic reactive hyperemia and obtained blood samples before and 2 h after the test meal. Pravastatin 20 mg/day was then commenced in the 26 AP patients. The above tests were repeated after 2 days and 6 months. Maximum FBF during hyperemia in the baseline fasting phase was significantly lower in the AP patients than in the controls (p < 0.05). Fasting and postprandial FBF during reactive hyperemia time-dependently improved after pravastatin treatment (p < 0.05 vs. baseline data for each phase). Pravastatin treatment for 6 months, but not for 2 days, inhibited leukocyte activation and improved hemorheological parameters. In conclusion, pravastatin treatment for 6 months improved fasting and postprandial endothelial and hemorheological dysfunction in AP patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. McNamara JR, Shah PK, Nakajima K, Cupples LA, Wilson PW, Ordovas JM, Schaefer EJ (2001) Remnant-like particle (RLP) cholesterol is an independent cardiovascular disease risk factor in women: results from the Framingham Heart Study. Atherosclerosis 154(1):229–236

    Article  CAS  Google Scholar 

  2. Ginsberg HN, Jones J, Blaner WS, Thomas A, Karmally W, Fields L, Blood D, Begg MD (1995) Association of postprandial triglyceride and retinyl palmitate responses with newly diagnosed exercise-induced myocardial ischemia in middle-aged men and women. Arterioscler Thromb Vasc Biol 15(11):1829–1838

    Article  CAS  Google Scholar 

  3. Gotto AM Jr (1998) Triglyceride: the forgotten risk factor. Circulation 97(11):1027–1028

    Article  PubMed  Google Scholar 

  4. Kugiyama K, Doi H, Motoyama T, Soejima H, Misumi K, Kawano H, Nakagawa O, Yoshimura M, Ogawa H, Matsumura T, Sugiyama S, Nakano T, Nakajima K, Yasue H (1998) Association of remnant lipoprotein levels with impairment of endothelium-dependent vasomotor function in human coronary arteries. Circulation 97(25):2519–2526

    Article  CAS  PubMed  Google Scholar 

  5. DECODE study group; European Diabetes Epidemiology Group (1998) Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Reanalysis of European epidemiological data. DECODE Study Group on behalf of the European Diabetes Epidemiology Study Group. BMJ 317(7155):371–375

    Article  Google Scholar 

  6. DECODE study group; European Diabetes Epidemiology Group (1999) Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis Of Diagnostic criteria in Europe. Lancet 354(9179):617–621

    Article  Google Scholar 

  7. DECODE study group (2002) Cardiovascular risk profile assessment in glucose-intolerant Asian individuals—an evaluation of the World Health Organization two-step strategy: the DECODA Study (Diabetes Epidemiology: Collaborative Analysis of Diagnostic Criteria in Asia). Diabet Med 19(7):549–557

    Article  Google Scholar 

  8. Nakagami T; DECODA Study Group (2004) Hyperglycaemia and mortality from all causes and from cardiovascular disease in five populations of Asian origin. Diabetologia 47(3):385–394

    Article  CAS  PubMed  Google Scholar 

  9. Tominaga M, Eguchi H, Manaka H, Igarashi K, Kato T, Sekikawa A (1999) Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The funagata diabetes study. Diabetes Care 22(6):920–924

    Article  CAS  Google Scholar 

  10. Raitakari OT, Lai N, Griffiths K, McCredie R, Sullivan D, Celermajer DS (2000) Enhanced peripheral vasodilation in humans after a fatty meal. J Am Coll Cardiol 36(2):417–422

    Article  CAS  PubMed  Google Scholar 

  11. Vogel RA, Corretti MC, Plotnick GD (1997) Effect of a single high-fat meal on endothelial function in healthy subjects. Am J Cardiol 79(3):350–354

    Article  CAS  PubMed  Google Scholar 

  12. Gudmundsson GS, Sinkey CA, Chenard CA, Stumbo PJ, Haynes WG (2000) Resistance vessel endothelial function in healthy humans during transient postprandial hypertriglyceridemia. Am J Cardiol 85(3):381–385

    Article  CAS  Google Scholar 

  13. Bae JH, Bassenge E, Lee HJ, Park KR, Park CG, Park KY, Lee MS, Schwemmer M (2001) Impact of postprandial hypertriglyceridemia on vascular responses in patients with coronary artery disease: effects of ACE inhibitors and fibrates. Atherosclerosis 158(1):165–171

    Article  CAS  PubMed  Google Scholar 

  14. Lundman P, Eriksson MJ, Stühlinger M, Cooke JP, Hamsten A, Tornvall P (2001) Mild-to-moderate hypertriglyceridemia in young men is associated with endothelial dysfunction and increased plasma concentrations of asymmetric dimethylarginine. J Am Coll Cardiol 38(1):111–116

    Article  CAS  PubMed  Google Scholar 

  15. Gokce N, Duffy SJ, Hunter LM, Keaney JF, Vita JA (2001) Acute hypertriglyceridemia is associated with peripheral vasodilation and increased basal flow in healthy young adults. Am J Cardiol 88(2):153–159

    Article  CAS  PubMed  Google Scholar 

  16. Bae JH, Bassenge E, Kim KB, Kim YN, Kim KS, Lee HJ, Moon KC, Lee MS, Park KY, Schwemmer M (2001) Postprandial hypertriglyceridemia impairs endothelial function by enhanced oxidant stress. Atherosclerosis 155(2):517–523

    Article  CAS  PubMed  Google Scholar 

  17. Katz DL, Nawaz H, Boukhalil J, Giannamore V, Chan W, Ahmadi R, Sarrel PM (2001) Acute effects of oats and vitamin E on endothelial responses to ingested fat. Am J Prev Med 20(2):124–129

    Article  CAS  PubMed  Google Scholar 

  18. Marchesi S, Lupattelli G, Schillaci G, Pirro M, Siepi D, Roscini AR, Pasqualini L, Mannarino E (2000) Impaired flow-mediated vasoactivity during post-prandial phase in young healthy men. Atherosclerosis 153(2):397–402

    Article  CAS  Google Scholar 

  19. Feldman CL, Stone PH (2000) Intravascular hemodynamic factors responsible for progression of coronary atherosclerosis and development of vulnerable plaque. Curr Opin Cardiol 15(6):430–440

    Article  CAS  PubMed  Google Scholar 

  20. Kikuchi Y, Sato K, Mizuguchi Y (1994) Modified cell-flow microchannels in a single-crystal silicon substrate and flow behavior of blood cells. Microvasc Res 47(1):126–139

    Article  CAS  PubMed  Google Scholar 

  21. Kikuchi Y (1995) Effect of leukocytes and platelets on blood flow through a parallel array of microchannels: micro- and macroflow relation and rheological measures of leukocyte and platelet activities. Microvasc Res 50(2):288–300

    Article  CAS  PubMed  Google Scholar 

  22. Ridker PM, Rifai N, Pfeffer MA, Sacks F, Braunwald E (1999) Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators. Circulation 100(3):230–235

    Article  CAS  PubMed  Google Scholar 

  23. Lacoste L, Lam JY, Hung J, Letchacovski G, Solymoss CB, Waters D (1995) Hyperlipidemia and coronary disease. Correction of the increased thrombogenic potential with cholesterol reduction. Circulation 92(11):3172–3177

    Article  CAS  PubMed  Google Scholar 

  24. Tsuda Y, Satoh K, Kitadai M, Takahashi T, Izumi Y, Hosomi N (1996) Effects of pravastatin sodium and simvastatin on plasma fibrinogen level and blood rheology in type II hyperlipoproteinemia. Atherosclerosis 122(2):225–233

    Article  CAS  PubMed  Google Scholar 

  25. Dajani EZ, Shahwan TG, Dajani NE (2002) Statins, platelet aggregation and coronary heart disease. J Assoc Acad Minor Phys 13(1):27–31

    PubMed  Google Scholar 

  26. Salonen R, Nyssönen K, Porkkala-Sarataho E, Salonen JT (1995) The Kuopio Atherosclerosis Prevention Study (KAPS): effect of pravastatin treatment on lipids, oxidation resistance of lipoproteins, and atherosclerotic progression. Am J Cardiol 76(9):34 C-39 C

  27. Arao K, Yasu T, Umemoto T, Jinbo S, Ikeda N, Ueda S, Kawakami M, Momomura S (2009) Effects of pitavastatin on postprandial endothelial function, oxidative stress, and hemorheology in patients with stable angina pectoris. Circ J 73:1523–1530

    Article  CAS  PubMed  Google Scholar 

  28. Egashira K, Hirooka Y, Kai H, Sugimachi M, Suzuki S, Inou T, Takeshita A (1994) Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia. Circulation 89(6):2519–2524

    Article  CAS  PubMed  Google Scholar 

  29. Iijima R, Ndrepepa G, Kujath V, Harada Y, Kufner S, Schunkert H, Nakamura M, Kastrati A (2016) A pan-coronary artery angiographic study of the association between diabetes mellitus and progression or regression of coronary atherosclerosis. Heart Vessels. doi:10.1007/s00380-016-0889-8

    Google Scholar 

  30. Okumura K, Tsukamoto H, Tsuboi H, Hirayama H, Kamiya H, Watarai M, Ishiki R, Murohara T; Samurai Study Investigators (2015) High HDL cholesterol level after treatment with pitavastatin is an important factor for regression in carotid intima-media thickness. Heart Vessels 30(2):154–161

    Article  Google Scholar 

  31. Nozue T, Yamamoto S, Tohyama S, Fukui K, Umezawa S, Onishi Y, Kunishima T, Sato A, Nozato T, Miyake S, Takeyama Y, Morino Y, Yamauchi T, Muramatsu T, Hibi K, Terashima M, Michishita I (2015) Comparison of the effects of pitavastatin versus pravastatin on coronary artery plaque phenotype assessed by tissue characterization using serial virtual histology intravascular ultrasound. Heart Vessels 30(1):36–44

    Article  PubMed  Google Scholar 

  32. Nakamura H, Arakawa K, Itakura H, Kitabatake A, Goto Y, Toyota T, Nakaya N, Nishimoto S, Muranaka M, Yamamoto A, Mizuno K, Ohashi Y; MEGA Study Group (2006) Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial. Lancet 368(9542):1155–1163

    Article  CAS  PubMed  Google Scholar 

  33. Higashi Y, Sasaki S, Sasaki N, Nakagawa K, Ueda T, Yoshimizu A, Kurisu S, Matsuura H, Kajiyama G, Oshima T (1999) Daily aerobic exercise improves reactive hyperemia in patients with essential hypertension. Hypertension 33:591–597

    Article  CAS  PubMed  Google Scholar 

  34. Fukuda S, Yasu T, Predescu DN, Schmid-Schönbein GW (2000) Mechanisms for regulation of fluid shear stress response in circulating leukocytes. Circ Res 86(1):E13–E18

    Article  CAS  PubMed  Google Scholar 

  35. Fukuda S, Yasu T, Kobayashi N, Ikeda N, Schmid-Schönbein GW (2004) Contribution of fluid shear response in leukocytes to hemodynamic resistance in the spontaneously hypertensive rat. Circ Res 95(1):100–108

    Article  CAS  PubMed  Google Scholar 

  36. Zhao SP, Liu L, Gao M, Zhou QC, Li YL, Xia B (2001) Impairment of endothelial function after a high-fat meal in patients with coronary artery disease. Coron Artery Dis 12(7):561–565

    Article  CAS  Google Scholar 

  37. Strey CH, Young J, Collier M, Florkowski CM, Shand BI, Scott RS (2004) The postprandial state does not impair endothelial function in women with type 2 diabetes, irrespective of glycaemic control. Diabetologia 47(10):1838–1846

    Article  CAS  PubMed  Google Scholar 

  38. Muntwyler J, Sütsch G, Kim JH, Schmid H, Follath F, Kiowski W, Amann FW (2001) Post-prandial lipaemia and endothelial function among healthy men. Swiss Med Wkly 131(15–16):214–218

    CAS  Google Scholar 

  39. Brun JF (2002) Hormones, metabolism and body composition as major determinants of blood rheology: potential pathophysiological meaning. Clin Hemorheol Microcirc 26(2):63–79

    CAS  PubMed  Google Scholar 

  40. Fukuda I, Yoshida T, Yoritsune H, Kiso T, Konishi S, Kawasaki T, Mozai T (1978) Studies on the hemorheological factors in ischemic heart disease and cerebrovascular disorders. Bull Osaka Med Sch 24(2):83–91

    CAS  Google Scholar 

  41. Otto C, Pschierer V, Soennichsen AC, Schwandt P, Richter WO (1997) Postprandial hemorheology and apolipoprotein B metabolism in patients with familial hypertriglyceridemia. Metabolism 46(11):1299–1304

    Article  CAS  PubMed  Google Scholar 

  42. Kurihara T, Deguchi S, Kato J, Furakawa M, Tsuchiya M, Akimoto M, Ishiguro H, Hashimoto H, Niimi A, Maeda A, Shigemoto M, Yamashita K, Kawakami A, Umemura K, Nakashima M, Nakano T, Saniabadi AR (2001) Impaired blood rheology by remnant-like lipoprotein particles: studies in patients with fatty liver disease. Clin Hemorheol Microcirc 24(4):217–225

    CAS  PubMed  Google Scholar 

  43. Hernández-Perera O, Pérez-Sala D, Navarro-Antolín J, Sánchez-Pascuala R, Hernández G, Díaz C, Lamas S (1998) Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells. J Clin Invest 101(12):2711–2719

    Article  PubMed  PubMed Central  Google Scholar 

  44. Kureishi Y, Luo Z, Shiojima I, Bialik A, Fulton D, Lefer DJ, Sessa WC, Walsh K (2000) The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nat Med 6(9):1004–1010

    Article  CAS  PubMed Central  Google Scholar 

  45. Omori H, Nagashima H, Tsurumi Y, Takagi A, Ishizuka N, Hagiwara N, Kawana M, Kasanuki H (2002) Direct in vivo evidence of a vascular statin: a single dose of cerivastatin rapidly increases vascular endothelial responsiveness in healthy normocholesterolaemic subjects. Br J Clin Pharmacol 54(4):395–399

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Wilmink HW, Twickler MB, Banga JD, Dallinga-Thie GM, Eeltink H, Erkelens DW, Rabelink TJ, Stroes ES (2001) Effect of statin versus fibrate on postprandial endothelial dysfunction: role of remnant-like particles. Cardiovasc Res 50(3):577–582

    Article  CAS  PubMed  Google Scholar 

  47. Ceriello A, Taboga C, Tonutti L, Quagliaro L, Piconi L, Bais B, Da Ros R, Motz E (2002) Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation: effects of short- and long-term simvastatin treatment. Circulation 106(10):1211–1218

    Article  PubMed  Google Scholar 

  48. Salonen R, Nyyssönen K, Porkkala E, Rummukainen J, Belder R, Park JS, Salonen JT (1995) Kuopio Atherosclerosis Prevention Study (KAPS). A population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries. Circulation 92(7):1758–1764

    Article  CAS  Google Scholar 

  49. Hayek T, Kaplan M, Kerry R, Aviram M (2007) Macrophage NADPH oxidase activation, impaired cholesterol fluxes, and increased cholesterol biosynthesis in diabetic mice: a stimulatory role for d-glucose. Atherosclerosis 195(2):277–286

    Article  CAS  Google Scholar 

  50. Lowe G, Rumley A, Norrie J, Ford I, Shepherd J, Cobbe S, Macfarlane P, Packard C (2000, 2001) Blood rheology, cardiovascular risk factors, and cardiovascular disease: the West of Scotland coronary prevention study. Thromb Haemost 84(4):553–558. Erratum in: Thromb Haemost 85(5):946

    Google Scholar 

  51. Di Garbo V, Bono M, Di Raimondo D, De Simone R, Raneli G, Avellone G (2000) Non lipid, dose-dependent effects of pravastatin treatment on hemostatic system and inflammatory response. Eur J Clin Pharmacol 56(4):277–284

    Article  CAS  Google Scholar 

  52. Dupuis J, Tardif JC, Cernacek P, Théroux P (1999) Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes. The RECIFE (reduction of cholesterol in ischemia and function of the endothelium) trial. Circulation 99(25):3227–3233

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors wish to thank Mrs. Sachimi Jimbo for the preparation and measurement of FBF via plethysmography and WBTT using the MC-FAN and Dr. Ikunosuke Sakurabayashi for the measurement of the lipid profile of each sample. We would like to thank Editage (http://www.editage.jp) for English language editing.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Takanori Yasu.

Ethics declarations

Sources of funding

This work was partly supported by Grants-in-Aid from the Ministry of Education, Science and Culture of Japan (26350581 to TY).

Conflict of interest

No conflicts of interest to declare.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Umemoto, T., Yasu, T., Arao, K. et al. Pravastatin improves postprandial endothelial dysfunction and hemorheological deterioration in patients with effort angina pectoris. Heart Vessels 32, 1051–1061 (2017). https://doi.org/10.1007/s00380-017-0974-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00380-017-0974-7

Keywords

Navigation